Reduced alpha power predicts recurrence risk in major depressive disorder

Area of Science:

• Neuroscience
• Psychiatry
• Biomarkers

Background:

• Recurrent major depressive disorder (MDD) episodes are common, necessitating better recurrence risk prediction.
• Electroencephalography (EEG) offers a scalable method for identifying potential recurrence markers.
• Frontal alpha asymmetry (FAA) and alpha band power are implicated in depression, but prospective recurrence studies are limited.

Purpose of the Study:

• To investigate frontal alpha power and FAA as predictors of future depressive episodes in remitted MDD patients.
• To assess the potential of EEG markers for identifying individuals at high risk of MDD recurrence.
• To inform the development of prophylactic treatments and support clinical decision-making for MDD.

Main Methods:

• Resting EEG was performed on 84 participants (53 remitted MDD, 31 controls).
• Remitted MDD patients were clinically followed for 14 months to track recurrence.
• Binary logistic regression models were used to predict recurrence risk based on EEG measures and clinical factors.

Main Results:

• Reduced frontal alpha power at baseline predicted recurrence in MDD patients compared to controls and stable remitters.
• Frontal alpha asymmetry (FAA) did not show significant group differences.
• Combining frontal alpha power with clinical predictors yielded an 88% accuracy in predicting recurrent episodes.

Conclusions:

• Reduced frontal alpha power shows promise as a biomarker for MDD recurrence risk.
• This EEG marker can potentially enhance MDD recurrence prediction models.
• Larger studies employing cross-validated prediction techniques are warranted to further validate these findings.